Riskpilot← Back to searchSign inGet full accessØRSTA INVEST AS
ASActiveOrg 990693560Voldavegen 26, 6155 ØrstaPhysiotherapy activities · NACE 8695Est. 20070 employees
Revenue 2024
NOK 0
EBITDA margin
—
-19% vs 2023
Equity ratio
44.1%
Financial strength
Net profit 2024
NOK 13K
+14% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -17K | -19% |
| Net profit | NOK 13K | +14% |
| Total assets | NOK 1,5M | +1% |
| Equity | NOK 661K | +2% |
| Employees | 0 | — |
Legal name
ØRSTA INVEST AS
Org number
990693560
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
11. januar 2007
Share capital
NOK 106 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styreleiar åleine.
Company purpose
Kjøp, sal og forvaltning av aksjar og partar i andre selskap og dessuten utøve dei funksjonane som normalt ligg under rolla som holdingselskap.
Address
Voldavegen 26, 6155 Ørsta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −12 | −11 | −15 | −15 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −12 | −11 | −15 | −15 | −17 |
| Net financials | 30 | 33 | 36 | 29 | 34 |
| Profit before tax | 18 | 23 | 21 | 15 | 17 |
| Tax | 4 | 5 | 5 | 3 | 4 |
| Net profit | 14 | 18 | 16 | 11 | 13 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 466 | 1 460 | 1 460 | 1 481 | 1 497 |
| Equity | 602 | 620 | 636 | 648 | 661 |
| Long-term debt | 102 | 63 | 23 | 0 | 0 |
| Short-term debt | 761 | 778 | 801 | 833 | 837 |
| Total debt | 864 | 840 | 824 | 833 | 837 |
EBITDA margin
-1735900.0%
This company
15.8%
Market median
-10986809% vs market
20202024
Equity ratio
44.1%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
1302800.0%
This company
8.1%
Market median
+16083851% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JL Deputy Member | Deputy Member | 2007 |
GA Chief Executive Officer | Chief Executive Officer | 2007 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ØRSTA INVEST AS 
FYSIO 1 ASBoard members of ØRSTA INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joanne Leigh Picton Aarseth | Deputy Member | 0 companies |
| Geir Arne Aarseth | Chief Executive Officer | 0 companies |